These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 12559505

  • 1. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.
    Bjartmar C, Wujek JR, Trapp BD.
    J Neurol Sci; 2003 Feb 15; 206(2):165-71. PubMed ID: 12559505
    [Abstract] [Full Text] [Related]

  • 2. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
    Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD.
    J Neuropathol Exp Neurol; 2002 Jan 15; 61(1):23-32. PubMed ID: 11829341
    [Abstract] [Full Text] [Related]

  • 3. [Neuronal injury in multiple sclerosis].
    Correale J, Meli F, Ysrraelit C.
    Medicina (B Aires); 2006 Jan 15; 66(5):472-85. PubMed ID: 17137182
    [Abstract] [Full Text] [Related]

  • 4. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D, Pham-Dinh D, Reynolds R.
    Exp Neurol; 2006 Feb 15; 197(2):373-85. PubMed ID: 16337942
    [Abstract] [Full Text] [Related]

  • 5. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J, Karacivi A, Stormanns ER, Recks MS, Kuerten S.
    PLoS One; 2015 Feb 15; 10(12):e0144847. PubMed ID: 26658811
    [Abstract] [Full Text] [Related]

  • 6. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
    Gresle MM, Shaw G, Jarrott B, Alexandrou EN, Friedhuber A, Kilpatrick TJ, Butzkueven H.
    J Neurosci Res; 2008 Dec 15; 86(16):3548-55. PubMed ID: 18709652
    [Abstract] [Full Text] [Related]

  • 7. Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
    Jackson SJ, Lee J, Nikodemova M, Fabry Z, Duncan ID.
    J Neuropathol Exp Neurol; 2009 Jun 15; 68(6):616-25. PubMed ID: 19458548
    [Abstract] [Full Text] [Related]

  • 8. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov 15; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 9. Axonal degeneration and progressive neurologic disability in multiple sclerosis.
    Bjartmar C, Trapp BD.
    Neurotox Res; 2003 Nov 15; 5(1-2):157-64. PubMed ID: 12832230
    [Abstract] [Full Text] [Related]

  • 10. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Kornek B, Storch MK, Bauer J, Djamshidian A, Weissert R, Wallstroem E, Stefferl A, Zimprich F, Olsson T, Linington C, Schmidbauer M, Lassmann H.
    Brain; 2001 Jun 15; 124(Pt 6):1114-24. PubMed ID: 11353727
    [Abstract] [Full Text] [Related]

  • 11. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
    Petratos S, Azari MF, Ozturk E, Papadopoulos R, Bernard CC.
    J Neuropathol Exp Neurol; 2010 Apr 15; 69(4):323-34. PubMed ID: 20448478
    [Abstract] [Full Text] [Related]

  • 12. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL, Wolak K, Fournier S, David S.
    Glia; 2010 Mar 15; 58(4):434-45. PubMed ID: 19780195
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y, Nomura T, Bochimoto H, Murakami K, Tanaka T, Watanabe T, Yoshida S.
    Neurochem Int; 2015 Feb 15; 81():16-27. PubMed ID: 25595039
    [Abstract] [Full Text] [Related]

  • 15. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H.
    Exp Neurol; 2010 Sep 15; 225(1):2-8. PubMed ID: 19840788
    [Abstract] [Full Text] [Related]

  • 16. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
    Forte M, Gold BG, Marracci G, Chaudhary P, Basso E, Johnsen D, Yu X, Fowlkes J, Rahder M, Stem K, Bernardi P, Bourdette D.
    Proc Natl Acad Sci U S A; 2007 May 01; 104(18):7558-63. PubMed ID: 17463082
    [Abstract] [Full Text] [Related]

  • 17. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S, Dallenga T, Winkler A, Roemer S, Maruschak B, Siebert H, Brück W, Stadelmann C.
    J Neuroinflammation; 2017 Mar 17; 14(1):57. PubMed ID: 28302146
    [Abstract] [Full Text] [Related]

  • 18. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E, Pardo LA, Gold R, Linker RA.
    Neurobiol Dis; 2008 May 17; 30(2):162-73. PubMed ID: 18342527
    [Abstract] [Full Text] [Related]

  • 19. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
    Bannerman PG, Hahn A.
    J Neurol Sci; 2007 Sep 15; 260(1-2):23-32. PubMed ID: 17493638
    [Abstract] [Full Text] [Related]

  • 20. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS, Stormanns ER, Bader J, Arnhold S, Addicks K, Kuerten S.
    Clin Immunol; 2013 Oct 15; 149(1):32-45. PubMed ID: 23899992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.